Lavreysen, H., Langlois, X., Donck, L. V., Nuñez, J. M. C., Pype, S., Lütjens, R., & Megens, A. (2015). Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813. Pharmacol Res Perspect.
Dyfyniad Arddull ChicagoLavreysen, Hilde, Xavier Langlois, Luc Ver Donck, José María Cid Nuñez, Stefan Pype, Robert Lütjens, and Anton Megens. "Preclinical Evaluation of the Antipsychotic Potential of the MGlu2-positive Allosteric Modulator JNJ-40411813." Pharmacol Res Perspect 2015.
Dyfyniad MLALavreysen, Hilde, et al. "Preclinical Evaluation of the Antipsychotic Potential of the MGlu2-positive Allosteric Modulator JNJ-40411813." Pharmacol Res Perspect 2015.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.